HealthCCSng vs KardiaAI
AI Verdict
Choose HealthCCSng if…
Choose HealthCCSng if your primary goal is to proactively assess a patient's long-term risk of coronary artery disease by leveraging existing routine chest CT scans. This tool is ideal for automatically detecting and quantifying coronary artery calcification, providing valuable insights into cardiovascular risk without requiring additional dedicated imaging.
View HealthCCSng →Choose KardiaAI if…
Choose KardiaAI if you need an AI-powered solution for analyzing ambulatory ECG rhythms to detect various cardiac arrhythmias, such as AFib, bradycardia, and tachycardia. This tool is best suited for scenarios requiring accurate, medical-grade detection of heart rhythm disorders from ECG data, often in a remote monitoring or integrated device context.
View KardiaAI →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | HealthCCSng | KardiaAI |
|---|---|---|
| Pricing | Not publicly available | Subscription-based for advanced features and services. |
| Deployment | Cloud-based, integrates with PACS and EMR systems | Mobile app, cloud-based. |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Yes AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
HealthCCSngHealthCCSng (Tool A) offers seamless integration with existing PACS and EMR systems and an automated workflow, making it highly usable for healthcare professionals within their established clinical routines. KardiaAI (Tool B), while enabling mobile applications, primarily functions as an API library, requiring integration by developers and separate device interaction for end-users.
Clinical Value
TieBoth tools are FDA-cleared and provide significant clinical value in distinct areas of cardiology. HealthCCSng aids in identifying patients at risk of coronary artery disease by quantifying CAC from routine CT scans, while KardiaAI detects various cardiac arrhythmias from ambulatory ECG rhythms. Their value is high but addresses different clinical problems.
Pricing & Value
KardiaAIKardiaAI (Tool B) offers transparent, publicly available subscription-based pricing with clear tiers, allowing for easy assessment of its value proposition. HealthCCSng (Tool A) does not publicly disclose its pricing, requiring direct vendor contact, which makes it difficult to evaluate its cost-effectiveness without further inquiry.
Enterprise Readiness
HealthCCSngHealthCCSng (Tool A) is explicitly designed for enterprise deployment, featuring cloud-based architecture, seamless integration with PACS and EMR systems, and automated workflows, making it well-suited for direct adoption within hospital IT infrastructures. While KardiaAI (Tool B) is HIPAA compliant and FDA cleared, its deployment as an API library suggests readiness for integration into other applications or devices rather than direct hospital system integration for imaging workflows.
Innovation
HealthCCSngHealthCCSng (Tool A) demonstrates strong innovation by leveraging existing, routine non-contrast, non-ECG gated CT scans to automatically detect and quantify coronary artery calcification, thereby identifying at-risk patients without the need for additional dedicated imaging. This opportunistic screening approach from readily available data presents a novel way to enhance patient risk stratification.
Support & Docs
KardiaAIAliveCor, the company behind KardiaAI (Tool B), provides extensive public support resources and user manuals for its KardiaMobile devices and KardiaCare services, which utilize the KardiaAI platform. In contrast, HealthCCSng (Tool A), as an enterprise solution, does not have readily available public documentation or support portals, with support likely handled through direct vendor agreements.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | HealthCCSng | KardiaAI |
|---|---|---|
| Name | HealthCCSng | KardiaAI |
| Company | Nano-X AI | AliveCor |
| Primary Function | Analyzes routine CT scans to automatically detect and quantify coronary artery calcification (CAC), identifying patients at risk of coronary artery disease. | AI software library for analyzing ambulatory ECG rhythms, detecting various cardiac conditions like AFib, bradycardia, and tachycardia. |
| Primary Data Input | Routine CT scans (non-contrast, non-ECG gated chest CT scans) | Ambulatory ECG rhythms |
| Key Detections/Analysis | Automatically detects and quantifies coronary artery calcification (CAC); Categorizes studies into 'zero', 'low', 'moderate', and 'severe' CAC categories; Generates a numerical calcium score; Provides visualization of calcified plaques within coronary arteries. | Detection of atrial fibrillation, bradycardia, tachycardia, and normal sinus rhythm; Detection of Sinus Rhythm with Premature Ventricular Contractions (PVCs); Detection of Sinus Rhythm with Wide QRS; Detection of Sinus Rhythm with Supraventricular Ectopy (SVE); ECG noise filtering and noisy ECG detection. |
| Integration Capabilities | Seamless integration with PACS and EMR systems | API library for integration into other ECG devices and software |
Videos
Demos, reviews, and walkthroughs featuring HealthCCSng and KardiaAI.
Frequently Asked Questions
More Comparisons
More matchups featuring HealthCCSng or KardiaAI
Backers
Who funded each tool's parent company.